CureVac
Sybille Zitzmann has extensive work experience in various roles within the clinical research field. Sybille currently holds the position of Associate Director Clinical Operations at CureVac, starting in November 2022. Prior to that, they worked as a Senior Project Manager at CureVac from August 2021 to October 2022. Before joining CureVac, Sybille held multiple roles at PSI CRO AG, including Senior Project Manager from April 2021 to July 2021, Lead Project Manager from July 2020 to April 2021, and Project Manager from June 2016 to July 2020. Sybille also worked at GCP-Service Int. Ltd. & Co. KG as a Project Manager/Regional Operational Manager from January 2008 to May 2016. Sybille's earlier experience includes working as a Customer Relation Specialist at gkk DialogGroup GmbH from September 2006 to November 2007 and as a Research Scientist at Max Planck Institute for Marine Microbiology from June 2002 to August 2006.
Sybille Zitzmann obtained their Master of Science (MSc) degree in Biology from Kiel University from 1996 to 2002.
This person is not in any offices
CureVac
8 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.